Pacific Biosciences of California, Inc. Stock
Stocks
PACB
US69404D1081
Advanced Medical Equipment & Technology
|
Market Closed -
Nasdaq
16:00:00 2026-09-04 EDT
|
5-day change | 1st Jan Change | ||
| 1.350 USD | +3.85% |
|
-3.57% | -27.81% |
| Market Cap | 420M 361M 340M 310M 581M 39.62B 582M 4.01B 1.56B 20.33B 1.58B 1.54B 65.48B | P/E 2026 * |
-3.07x | P/E 2027 * | -2.91x |
|---|---|---|---|---|---|
| Enterprise Value | 420M 361M 340M 310M 581M 39.62B 582M 4.01B 1.56B 20.33B 1.58B 1.54B 65.48B | EV / Sales 2026 * |
2.65x | EV / Sales 2027 * | 2.28x |
| Free-Float |
91.09% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| PACB | Delayed | |
CBOE
| PACB | Real-time | |
|
Tradegate
| P09 | Real-time | |
|
Deutsche Boerse AG
| P09 | Delayed | |
|
Börse Stuttgart
| P09 | Delayed | |
|
Boerse Muenchen
| P09 | Real-time |
Last Transcript : Pacific Biosciences of California, Inc.
| 1 day | +3.85% | ||
| 1 week | -3.57% | ||
| Current month | -0.37% | ||
| 1 month | +15.88% | ||
| 3 months | -6.90% | ||
| 6 months | -2.17% | ||
| Current year | -27.81% |
| 1 week | 1.28 |  | 1.35 |
| 1 month | 1.07 | | 1.61 |
| Current year | 1.07 | | 2.73 |
| 1 year | 1.07 | | 2.73 |
| 3 years | 0.85 | | 11.96 |
| 5 years | 0.85 | | 31.1 |
| 10 years | 0.85 | | 53.69 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mark van Oene
CEO | Chief Executive Officer | 53 | 2026-08-04 |
Jim Gibson
DFI | Director of Finance/CFO | 57 | 2025-03-30 |
Jonas Korlach
CTO | Chief Tech/Sci/R&D Officer | - | 2012-06-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Bill Ericson
BRD | Director/Board Member | 67 | 2003-12-31 |
Randy Livingston
BRD | Director/Board Member | 72 | 2008-12-31 |
Marshall Mohr
BRD | Director/Board Member | 69 | 2012-01-17 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/17/26 | Sell | Chief Executive Officer | -26,911 | 0.0087% | ||
| 8/10/26 | Free | Chief Executive Officer | 2,457,018 | 0.7911% | ||
| 6/3/26 | Free | Chairman | 223,492 | 0.0720% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.85% | -3.57% | +6.30% | -87.84% | 420M | |
| -0.75% | -1.35% | +24.60% | +14.36% | 227B | |
| -1.60% | -3.89% | +3.72% | -19.20% | 146B | |
| -0.85% | -1.58% | -21.45% | +19.12% | 130B | |
| +1.81% | +2.05% | -55.42% | -11.25% | 69.27B | |
| +0.13% | -0.34% | +11.07% | +16.81% | 51.82B | |
| +0.49% | -1.32% | -17.44% | -13.37% | 50.45B | |
| +0.59% | -1.94% | +17.17% | +27.91% | 42.53B | |
| -1.01% | -1.28% | +33.64% | +50.03% | 40.22B | |
| -1.55% | +1.22% | +120.58% | +36.40% | 32.95B | |
| Average | +0.05% | -1.20% | +12.28% | +3.30% | 79.01B | |
| Weighted average by Cap. | -0.57% | -1.41% | +6.66% | +8.50% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 158M 136M 128M 117M 219M 14.94B 219M 1.51B 587M 7.66B 594M 581M 24.69B | 184M 158M 149M 136M 255M 17.37B 255M 1.76B 683M 8.91B 691M 676M 28.72B |
| Net income | -137M -118M -111M -101M -190M -12.94B -190M -1.31B -509M -6.64B -515M -504M -21.39B | -148M -127M -120M -109M -205M -13.96B -205M -1.41B -549M -7.16B -555M -543M -23.08B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-04 | US$1.350 | +3.85% | 2,764,523 |
| 26-09-03 | US$1.300 | -1.52% | 5,151,172 |
| 26-09-02 | US$1.320 | +3.13% | 5,938,826 |
| 26-09-01 | US$1.280 | -5.54% | 6,036,619 |
| 26-08-31 | US$1.355 | -3.21% | 6,083,174 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PACB Stock
Select your edition
All financial news and data tailored to specific country editions
